Results 161 to 170 of about 4,918,610 (234)

Efficacy of pro-haemostatic agents in the management of factor Xa inhibitor-associated intracranial haemorrhages. [PDF]

Intern Med J
Ng SS, Noori H, Nguyen D, Wang Z, Hsu D.
europepmc   +1 more source

Impact of Age and Factor Xa Inhibitor Concentrations on Bleeding Risk in Patients with Atrial Fibrillation. [PDF]

Clin Pharmacol Ther
Lin SY, Liu YB, Ho LT, Kuo CH, Peng YF, Huang CF, Tang SC, Jeng JS.   +7 more
europepmc   +1 more source

Factor Xa Inhibitor

Japanese Journal of Thrombosis and Hemostasis, 2003
Takashi KOIZUMI, Masahiko UCHIDA
openaire   +2 more sources

Case Report: IVC-agenesis and FVL mutation; successful DVT/PE treatment with direct oral anticoagulation (factor Xa inhibitor). [PDF]

Front Cardiovasc Med
Siddiqui A, Hatfield T, Nguyen Q, Waris W.   +3 more
europepmc   +1 more source

Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage: The prospective observational multicenter ASTRO-DE study. [PDF]

Int J Stroke
Diener HC, Kuklik N, Hüsing A, Alonso A, Nabavi DG, Poli S, Gabriel MM, Maier IL, Grans J.   +8 more
europepmc   +1 more source

Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding. [PDF]

Res Pract Thromb Haemost
Lucarelli S, Derry K, Atallah S, Stevens C.   +3 more
europepmc   +1 more source

Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa. [PDF]

J Thromb Haemost, 2020
Nederpelt CJ, Naar L, Sylvester KW, Barra ME, Roberts RJ, Velmahos GC, Kaafarani HMA, Rosenthal MG, King DR.   +8 more
europepmc   +1 more source

Reply to "Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding". [PDF]

Res Pract Thromb Haemost
Dobesh PP, Fermann GJ, Christoph MJ, Koch B, Lesén E, Chen H, Lovelace B, Dettling T, Danese M, Ulloa J, Danese S, Coleman CI.   +11 more
europepmc   +1 more source

Management of factor Xa inhibitor-related traumatic non-intracranial bleeding events with andexanet alfa or four-factor prothrombin complex concentrate in a US multicenter observational study. [PDF]

J Am Coll Emerg Physicians Open
Dobesh PP, Coleman CI, Danese M, Lesén E, Chang RC, Odelade O, Fermann GJ.   +6 more
europepmc   +1 more source

Perinephric Hematoma Induced by Factor Xa Inhibitor in a Patient with a Vascular Renal Mass. [PDF]

J Transl Int Med, 2020
Hussaini SA, Bakhsh ARA.
europepmc   +1 more source